欧洲患者对亚托邦性皮炎治疗的偏好:一个离散选择实验

Katja C Heinz1, Charlotte Beaudart2, Axel De Greef3,4

  • 1Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.

概括

对于欧洲成年患者来说,皮炎 (AD) 减少是最关键的治疗属性. 了解这些偏好可以指导开发更合适的AD疗法.